Biogen halts studies of closely watched Alzheimer’s drug, a blow to hopes for new treatment
(By Adam Feuerstein for STAT) Alzheimer’s disease has beaten back another effort to tame it. Biogen and its Japanese pharma
Read More
“Affordability boards” to review expensive drugs
To rein in prescription drug prices, several states are considering new “affordability boards” to review expensive drugs and if it
Read MorePrescribing food as medicine is more cost effective
A new study suggests that prescriptions for healthy foods cold help lower the risk of expensive chronic illnesses like cardiovascular
Read MoreFentanyl-Linked Deaths: The U.S. Opioid Epidemic’s Third Wave
(By Martha Bebinger for NPR) Men are dying after opioid overdoses at nearly three times the rate of women in
Read MoreBiosimilar approval and adoption in the U.S. needs to be expedited
(By Carlos Sattler and Sheila Frame for STAT) Generic versions of brand-name small-molecule drugs saved Americans more than $1 trillion between 1999
Read MoreCMS to revise fines on Medicare Advantage plans
(By Morgan Haefner for Becker’s Hospital Review) CMS is proposing an update to how it calculates fines imposed on Medicare
Read MoreHealth Plans For State Employees Use Medicare’s Hammer On Hospital Bills
States. They’re just as perplexed as the rest of us over the ever-rising cost of health care premiums. Now some
Read MoreMedicare – no routine dental coverage
Medicare covers approximately 60 million Americans and about 65 percent or 37 million people, do not have dental coverage. Medicare
Read MoreCostly Confusion: Medicare’s Wellness Visit Isn’t The Same As An Annual Physical
(By Michelle Andrews for Kaiser Health News) When Beverly Dunn called her new primary care doctor’s office last November to
Read MoreKnowledge is power when it comes to kidney health
(Source – www.medicare.gov/blog) Did you know that approximately 90% of people with kidney disease don’t even know they have it?
Read More